Year |
Citation |
Score |
2023 |
Larson JH, Jin S, Loschi M, Wagers SB, Thangavelu G, Zaiken MC, McDonald-Hyman C, Saha A, Aguilar EG, Koehn B, Osborn MJ, Panoskaltsis-Mortari A, Macdonald KPA, Hill GR, Murphy WJ, et al. Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 36878433 DOI: 10.1016/j.ajt.2023.01.030 |
0.43 |
|
2022 |
Lopes Ramos T, Bolivar-Wagers S, Jin S, Thangavelu G, Simonetta F, Lin PY, Hirai T, Saha A, Koehn BH, L Su L, Picton LK, Baker J, Lohmeyer JK, Riddle MJ, Eide C, et al. Prevention of acute GVHD disease using an orthogonal IL-2/IL-2Rβ system to selectively expand regulatory T-cells in vivo. Blood. PMID 36564052 DOI: 10.1182/blood.2022018440 |
0.403 |
|
2022 |
Bolivar-Wagers S, Loschi ML, Jin S, Thangavelu G, Larson JH, McDonald-Hyman CS, Aguilar EA, Saha A, Koehn BH, Hefazi M, Osborn MJ, Jensen MC, Wagner JE, Pennell CA, Blazar BR. Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses. Jci Insight. PMID 35917188 DOI: 10.1172/jci.insight.160674 |
0.518 |
|
2021 |
Walton K, Walker K, Riddle M, Koehn BH, Reff J, Sagatys EM, Linden MA, Pidala J, Kim J, Lee MC, Kiluk JV, Hui JYC, Yun SY, Xing Y, Stefanski H, et al. Dual JAK2/Aurora kinase A inhibition prevents human skin graft rejection by allo-inactivation and ILC2-mediated tissue repair. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. PMID 34668635 DOI: 10.1111/ajt.16870 |
0.388 |
|
2020 |
ElTanbouly MA, Zhao Y, Nowak E, Li J, Schaafsma E, Le Mercier I, Ceeraz S, Lines JL, Peng C, Carriere C, Huang X, Day M, Koehn B, Lee SW, Silva Morales M, et al. VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance. Science (New York, N.Y.). 367. PMID 31949051 DOI: 10.1126/Science.Aay0524 |
0.454 |
|
2019 |
Koehn BH, Saha A, McDonald-Hyman C, Loschi M, Thangavelu G, Ma L, Zaiken M, Dysthe J, Krepps W, Panthera J, Hippen K, Jameson SC, Miller JS, Cooper MA, Farady CJ, et al. Danger-associated extracellular ATP counters MDSC therapeutic efficacy in acute GvHD. Blood. PMID 31533918 DOI: 10.1182/Blood.2019001950 |
0.405 |
|
2019 |
Thangavelu G, Lee YC, Loschi M, Schaechter KM, Feser CJ, Koehn BH, Nowak EC, Zeiser R, Serody JS, Murphy WJ, Munn DH, Chambon P, Noelle RJ, Blazar BR. Dendritic Cell Expression of Retinal Aldehyde Dehydrogenase-2 Controls Graft-versus-Host Disease Lethality. Journal of Immunology (Baltimore, Md. : 1950). PMID 30885956 DOI: 10.4049/Jimmunol.1800899 |
0.487 |
|
2018 |
McDonald-Hyman C, Muller JT, Loschi M, Thangavelu G, Saha A, Kumari S, Reichenbach DK, Smith MJ, Zhang G, Koehn BH, Lin J, Mitchell JS, Fife BT, Panoskaltsis-Mortari A, Feser CJ, et al. The vimentin intermediate filament network restrains regulatory T-cell suppression of graft-versus-host disease. The Journal of Clinical Investigation. PMID 30106752 DOI: 10.1172/Jci95713 |
0.506 |
|
2018 |
Sharma MD, Rodriguez PC, Koehn BH, Baban B, Cui Y, Guo G, Shimoda M, Pacholczyk R, Shi H, Lee EJ, Xu H, Johnson TS, He Y, Mergoub T, Venable C, et al. Activation of p53 in Immature Myeloid Precursor Cells Controls Differentiation into Ly6c+CD103+ Monocytic Antigen-Presenting Cells in Tumors. Immunity. 48: 91-106.e6. PMID 29343444 DOI: 10.1016/J.Immuni.2017.12.014 |
0.503 |
|
2017 |
Koehn BH, Blazar BR. Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation. Journal of Leukocyte Biology. PMID 28148718 DOI: 10.1189/Jlb.5Mr1116-464R |
0.518 |
|
2016 |
Matta BM, Reichenbach DK, Zhang X, Mathews L, Koehn BH, Dwyer GK, Lott JM, Uhl FM, Pfeifer D, Feser CJ, Smith MJ, Liu Q, Zeiser R, Blazar BR, Turnquist HR. Peri-alloHCT IL-33 administration expands recipient T regulatory cells that protect mice against acute GVHD. Blood. PMID 27222477 DOI: 10.1182/Blood-2015-12-684142 |
0.416 |
|
2015 |
Koehn BH, Zeiser R, Blazar BR. Inflammasome effects in GvHD. Oncotarget. 6: 38444-5. PMID 26564963 DOI: 10.18632/Oncotarget.6307 |
0.517 |
|
2015 |
Koehn BH, Apostolova P, Haverkamp JM, Miller JS, McCullar V, Tolar J, Munn DH, Murphy WJ, Brickey WJ, Serody JS, Gabrilovich DI, Bronte V, Murray PJ, Ting JP, Zeiser R, et al. GVHD-associated, inflammasome-mediated loss of function in adoptively transferred myeloid-derived suppressor cells. Blood. 126: 1621-8. PMID 26265697 DOI: 10.1182/Blood-2015-03-634691 |
0.481 |
|
2015 |
Reichenbach DK, Schwarze V, Matta BM, Tkachev V, Lieberknecht E, Liu Q, Koehn BH, Pfeifer D, Taylor PA, Prinz G, Dierbach H, Stickel N, Beck Y, Warncke M, Junt T, et al. The IL-33/ST2 axis augments effector T-cell responses during acute GVHD. Blood. 125: 3183-92. PMID 25814531 DOI: 10.1182/Blood-2014-10-606830 |
0.453 |
|
2015 |
McDonald-Hyman C, Thangavelu G, Muller J, Zhang G, Kumari S, Saha A, Koehn BH, Mitchell JS, Fife BT, Serody JS, Osborn MJ, Hippen KL, Kelekar A, Munn DH, Altman A, et al. Protein Kinase C-Theta Interacts with mTORC2 and Vimentin to Limit Regulatory T-Cell Function Blood. 126: 849-849. DOI: 10.1182/Blood.V126.23.849.849 |
0.471 |
|
2014 |
Monjazeb AM, Tietze JK, Grossenbacher SK, Hsiao HH, Zamora AE, Mirsoian A, Koehn B, Blazar BR, Weiss JM, Wiltrout RH, Sckisel GD, Murphy WJ. Bystander activation and anti-tumor effects of CD8+ T cells following Interleukin-2 based immunotherapy is independent of CD4+ T cell help. Plos One. 9: e102709. PMID 25119341 DOI: 10.1371/Journal.Pone.0102709 |
0.563 |
|
2014 |
Reichenbach DK, Schwarze V, Matta BM, Tkachev V, Lieberknecht E, Liu Q, Koehn BH, Pfeifer D, Taylor PA, Prinz G, Dierbach H, Stickel N, Beck Y, Warncke M, Junt T, et al. Regulation of Immune Responses during Acute GvHD Via the IL-33/ST2 Axis Blood. 124: 844-844. DOI: 10.1182/Blood.V124.21.844.844 |
0.444 |
|
2013 |
Saha A, Aoyama K, Taylor PA, Koehn BH, Veenstra RG, Panoskaltsis-Mortari A, Munn DH, Murphy WJ, Azuma M, Yagita H, Fife BT, Sayegh MH, Najafian N, Socie G, Ahmed R, et al. Host programmed death ligand 1 is dominant over programmed death ligand 2 expression in regulating graft-versus-host disease lethality. Blood. 122: 3062-73. PMID 24030385 DOI: 10.1182/Blood-2013-05-500801 |
0.401 |
|
2013 |
Grossenbacher SK, Monjazeb AM, Tietze J, Sckisel GD, Mirsoian A, Hsiao H, Koehn B, Wilkins D, Blazer BR, Murphy WJ. Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells Journal For Immunotherapy of Cancer. 1. DOI: 10.1186/2051-1426-1-S1-P100 |
0.558 |
|
2012 |
Ferrer IR, Liu D, Pinelli DF, Koehn BH, Stempora LL, Ford ML. CD40/CD154 blockade inhibits dendritic cell expression of inflammatory cytokines but not costimulatory molecules. Journal of Immunology (Baltimore, Md. : 1950). 189: 4387-95. PMID 23002440 DOI: 10.4049/Jimmunol.1201757 |
0.705 |
|
2011 |
Floyd TL, Koehn BH, Kitchens WH, Robertson JM, Cheeseman JA, Stempora L, Larsen CP, Ford ML. Limiting the amount and duration of antigen exposure during priming increases memory T cell requirement for costimulation during recall. Journal of Immunology (Baltimore, Md. : 1950). 186: 2033-41. PMID 21257960 DOI: 10.4049/Jimmunol.1003015 |
0.653 |
|
2010 |
Highfill SL, Rodriguez PC, Zhou Q, Goetz CA, Koehn BH, Veenstra R, Taylor PA, Panoskaltsis-Mortari A, Serody JS, Munn DH, Tolar J, Ochoa AC, Blazar BR. Bone marrow myeloid-derived suppressor cells (MDSCs) inhibit graft-versus-host disease (GVHD) via an arginase-1-dependent mechanism that is up-regulated by interleukin-13. Blood. 116: 5738-47. PMID 20807889 DOI: 10.1182/Blood-2010-06-287839 |
0.44 |
|
2009 |
Koehn BH, Schoenberger SP. Tumor immunotherapy: making an immortal army. Nature Medicine. 15: 731-2. PMID 19584859 DOI: 10.1038/Nm0709-731 |
0.373 |
|
2008 |
Koehn BH, Ford ML, Ferrer IR, Borom K, Gangappa S, Kirk AD, Larsen CP. PD-1-dependent mechanisms maintain peripheral tolerance of donor-reactive CD8+ T cells to transplanted tissue. Journal of Immunology (Baltimore, Md. : 1950). 181: 5313-22. PMID 18832687 DOI: 10.4049/Jimmunol.181.8.5313 |
0.687 |
|
2007 |
Koehn BH, Williams MA, Borom K, Gangappa S, Pearson TC, Ahmed R, Larsen CP. Fully MHC-disparate mixed hemopoietic chimeras show specific defects in the control of chronic viral infections. Journal of Immunology (Baltimore, Md. : 1950). 179: 2616-26. PMID 17675525 DOI: 10.4049/Jimmunol.179.4.2616 |
0.609 |
|
2007 |
Ford ML, Koehn BH, Wagener ME, Jiang W, Gangappa S, Pearson TC, Larsen CP. Antigen-specific precursor frequency impacts T cell proliferation, differentiation, and requirement for costimulation. The Journal of Experimental Medicine. 204: 299-309. PMID 17261633 DOI: 10.1084/Jem.20062319 |
0.674 |
|
2006 |
Koehn B, Gangappa S, Miller JD, Ahmed R, Larsen CP. Patients, pathogens, and protective immunity: the relevance of virus-induced alloreactivity in transplantation. Journal of Immunology (Baltimore, Md. : 1950). 176: 2691-6. PMID 16493023 DOI: 10.4049/Jimmunol.176.5.2691 |
0.585 |
|
2006 |
Kean LS, Hamby K, Koehn B, Lee E, Coley S, Stempora L, Adams AB, Heiss E, Pearson TC, Larsen CP. NK cells mediate costimulation blockade-resistant rejection of allogeneic stem cells during nonmyeloablative transplantation. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 6: 292-304. PMID 16426313 DOI: 10.1111/J.1600-6143.2005.01172.X |
0.709 |
|
2006 |
Ford M, Koehn B, Wagener M, Borom K, Gangappa S, Pearson T, Larsen C. F.142. Inhibition of T-Cell Activation By CD28 and CD40L Blockade Is Influenced By T-Cell Precursor Frequency Clinical Immunology. 119: S100-S101. DOI: 10.1016/J.Clim.2006.04.182 |
0.614 |
|
2006 |
Koehn B, Borom K, Gangappa S, Pearson T, Larsen C. F.141. A Role for PD-1 in Maintaining Peripheral Tolerance to An Allogeneic Skin Graft Clinical Immunology. 119: S100. DOI: 10.1016/J.Clim.2006.04.181 |
0.529 |
|
2002 |
McGargill MA, Mayerova D, Stefanski HE, Koehn B, Parke EA, Jameson SC, Panoskaltsis-Mortari A, Hogquist KA. A spontaneous CD8 T cell-dependent autoimmune disease to an antigen expressed under the human keratin 14 promoter. Journal of Immunology (Baltimore, Md. : 1950). 169: 2141-7. PMID 12165543 DOI: 10.4049/Jimmunol.169.4.2141 |
0.425 |
|
Show low-probability matches. |